Evotec SE (EVO) Non-Current Deferred Tax Liability (2020 - 2026)
Evotec SE's (EVO) quarterly Non-Current Deferred Tax Liability came in at $14831.0 in Q1 2026, up 4.13% year-on-year from $14242.5 in Q1 2025, and down 13.53% quarter-over-quarter from $17152.2 in Q4 2025.
Evotec SE (EVO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $14831.0 for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $14831.0, up 4.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $14831.0 (up 4.13% YoY), and the FY2025 annual result was $17152.2, down 99.98% from the prior year.
- Non-Current Deferred Tax Liability came in at $14831.0 for Q1 2026 at Evotec SE, down from $17152.2 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $105.4 million in Q4 2024 to a low of $14242.5 in Q1 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $17152.2 (2025), against an average of $13.1 million.
- Across the five-year window, Non-Current Deferred Tax Liability surged 440.37% in 2024 and sank 99.98% in 2025, its largest moves.
- Evotec SE's Non-Current Deferred Tax Liability stood at $18.9 million in 2022, then climbed by 3.26% to $19.5 million in 2023, then soared by 440.37% to $105.4 million in 2024, then sank by 99.98% to $17152.2 in 2025, then slipped by 13.53% to $14831.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $14831.0 (Q1 2026), $17152.2 (Q4 2025), and $15947.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evotec SE | 570.60 Mn | 570.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,831.01 |
| Mar 31, 2026 | 14,831.01 |
| Dec 31, 2025 | 17,152.18 |
| Dec 31, 2025 | 17,152.18 |
| Sep 30, 2025 | 15,947.08 |
| Sep 30, 2025 | 15,947.08 |
| Jun 30, 2025 | 15,513.51 |
| Jun 30, 2025 | 15,513.51 |
| Mar 31, 2025 | 14,242.52 |
| Mar 31, 2025 | 14,242.52 |
| Dec 31, 2024 | 105.45 Mn |
| Dec 31, 2024 | 105.45 Mn |
| Sep 30, 2024 | 15,432.18 |
| Sep 30, 2024 | 15,432.18 |
| Dec 31, 2023 | 19.51 Mn |
| Dec 31, 2023 | 19.51 Mn |
| Dec 31, 2022 | 18.90 Mn |
| Dec 31, 2022 | 18.90 Mn |
| Sep 30, 2022 | 17,321.14 |
| Sep 30, 2022 | 17,321.14 |